Additionally, upon the addition of anti-IGFBP2 treatment to ICA + CUR + SCFAs + IgG, the tumor shrunk, Ki67 levels in the tumors decreased, and the tumor-promoting effect of SCFAs on tumor growth was weakened (Fig. 4D and E). The gene discussed is IGFBP2; the disease is neoplasm.